Fusion Pharmaceuticals Inc (FUSN)
21.44
-0.01
(-0.05%)
USD |
NASDAQ |
May 06, 09:42
Fusion Pharmaceuticals Stock Buybacks (Quarterly): -57.27M for Dec. 31, 2023
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -57.27M |
| September 30, 2023 | -0.045M |
| June 30, 2023 | -24.44M |
| March 31, 2023 | -63.37M |
| December 31, 2022 | -0.132M |
| September 30, 2022 | -3.981M |
| June 30, 2022 | -0.074M |
| March 31, 2022 | -1.627M |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | -197.62M |
| March 31, 2020 | |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-197.62M
Minimum
Jun 2020
--
Maximum
Jun 2019
-19.36M
Average
-0.0225M
Median
Stock Buybacks (Quarterly) Benchmarks
| AstraZeneca PLC | -6.00M |
| Landos Biopharma Inc | -16.57M |
| Perspective Therapeutics Inc | -0.364M |
| Acasti Pharma Inc | 0.00 |
| Aurinia Pharmaceuticals Inc | -- |